- Home
- MAT vs ELVN Comparison
MAT vs ELVN Comparison
Compare MAT & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAT | ELVN |
|---|---|---|
| Founded | 1945 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.2B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MAT | ELVN |
|---|---|---|
| Price | $16.09 | $51.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 14 |
| Target Price | $18.04 | ★ $74.33 |
| AVG Volume (30 Days) | ★ 5.6M | 1.5M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.17 |
| EPS | ★ 1.35 | N/A |
| Revenue | ★ $5,347,623,000.00 | N/A |
| Revenue This Year | $3.85 | N/A |
| Revenue Next Year | $5.44 | N/A |
| P/E Ratio | $11.87 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.40 | $14.79 |
| 52 Week High | $22.48 | $62.32 |
Technical Indicators
Market Signals| Indicator | MAT | ELVN |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 67.54 |
| Support Level | $14.21 | $37.77 |
| Resistance Level | $17.33 | $52.39 |
| Average True Range (ATR) | 0.60 | 2.17 |
| MACD | -0.05 | 1.29 |
| Stochastic Oscillator | 72.35 | 95.79 |
Price Performance
Historical ComparisonAbout MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the rest stemming from international markets.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.